About contrast mediacontrast agent
Contrast mediacontrast agents are chemicals used in diagnostic imaging procedures such as CT scans, MRIs, X-rays, ultrasounds, and related procedures. They enhance the internal structure of the body and provide high-quality images, which help in providing an accurate diagnosis. It is widely used in radiology, interventional radiology, and interventional cardiology.
Technavio's analysts forecast the global contrast mediacontrast agent market to grow at a CAGR of 6.95 percent over the period 2014-2019.
Covered in this report
The global contrast mediacontrast agent market can be segmented into three based on type: iodinated, gadolinium-based, and barium-based contrast mediacontrast agent. Iodinated contrast media is the most widely preferred, as it can be easily administered orally.
Technavio's report, Global Contrast MediaContrast Agent Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers North America, Europe, APAC, and ROW; it also covers the global biomedical metal market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key regions
• APAC
• Europe
• North America
• ROW
Key vendors
• Bayer Healthcare
• Bracco Diagnostic
• Covidien
• GE Healthcare
• Guerbet Group
Other prominent vendors
• Acusphere
• Alseres Pharmaceuticals
• Aposense
• Avid Radiopharmaceuticals
• Bayer Schering Pharma
• BEILU Pharmaceutical
• Cell>Point
• China Resources Double-crane Pharmaceutical
• Draximage
• Eisai
• Eli Lilly
• Endocyte
• Eusa Pharma
• Hovione FarmaCiencia
• Imcor Pharmaceutical
• Immunomedics
• Insight Agents
• Jiangsu Hengrui Medicine
• King Pharmaceuticals
• Lantheus Medical Imaging
• Macrocyclics
• MDS Nordion
• Nanopet Pharma
• Nanoscan Imaging
• Pharmacyclics
• Point Biomedical
• Sanochemia Pharmazeutika
• Shanghai Xudong Haipu Pharmaceutical
• Spago Imaging
• Subhra Pharma Private
• Taejoon Pharm
• VisEn Medical
• Yangtze River Pharmaceutical
Market driver
• Increased demand for diagnostic imaging
• For a full, detailed list, view our report
Market challenge
• Clinical studies revealing adverse effects associated with contrast media
• For a full, detailed list, view our report
Market trend
• Growth in medical imaging technology
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Global Contrast MediaContrast Agents Market
06.1 Market Size and Forecast
06.2 Five Forces Analysis
07. Market Segmentation by Product Type
07.1 Segmentation of Global Contrast MediaContrast Agents Market by Product Type
07.2 Segmentation of Global Contrast MediaContrast Agents Market by Product Type 2014
07.3 Global Iodinated Contrast Media Market
07.3.1 Market Outlook
07.4 Global Gadolinium-based Contrast Media Market
07.4.1 Market Outlook
07.5 Global Barium-based Contrast Media Market
07.5.1 Market Outlook
08. Market Segmentation by Medical Procedure
08.1 Segmentation of Global Contrast MediaContrast Agents Market by Medical Procedure 2014
08.1.1 Global X-ray, Ultrasound, and Fluoroscopy Market
08.1.2 Global CT Scan Market
08.1.3 Global MRI Scan Market
08.1.4 Global Nuclear Medicine Market
09. Market Segmentation by Application
09.1 Segmentation of Global Contrast MediaContrast Agents Market by Application 2014
10. Geographical Segmentation
10.1 Segmentation of Global Contrast MediaContrast Agents Market by Geography 2014-2019
10.2 Contrast MediaContrast Agents Market in North America
10.2.1 Market Size and Forecast
10.3 Contrast MediaContrast Agents Market in Europe
10.3.1 Market Size and Forecast
10.4 Contrast MediaContrast Agents Market in APAC
10.4.1 Market Size and Forecast
10.5 Contrast MediaContrast Agents Market in ROW
10.5.1 Market Size and Forecast
11. Key Leading Countries
11.1 US
11.2 China
11.3 India
12. Buying Criteria
13. Market Growth Drivers
14. Drivers and their Impact
15. Market Challenges
16. Impact of Drivers and Challenges
17. Market Trends
18. Trends and their Impact
19. Vendor Landscape
19.1 Competitive Scenario
19.2 Major Vendors Analysis 2014
19.3 Other Prominent Vendors
20. Key Vendor Analysis
20.1 Bayer HealthCare
20.1.1 Key Facts
20.1.2 Business Overview
20.1.3 Business Segmentation by Revenue 2013
20.1.4 Business Segmentation by Revenue 2012 and 2013
20.1.5 Geographical Segmentation by Revenue 2013
20.1.6 Business Strategy
20.1.7 Recent Developments
20.1.8 SWOT Analysis
20.2 Bracco Diagnostics
20.2.1 Key Facts
20.2.2 Business Overview
20.2.3 Products Categories
20.2.4 Recent Developments
20.2.5 SWOT Analysis
20.3 Covidien plc
20.3.1 Key Facts
20.3.2 Business Overview
20.3.3 Business Segmentation
20.3.4 Business Segmentation by Revenue 2012 and 2013
20.3.5 Geographical Segmentation by Revenue 2013
20.3.6 Business Strategy
20.3.7 Key Information
20.3.8 SWOT Analysis
20.4 GE Healthcare
20.4.1 Key Facts
20.4.2 Business Overview
20.4.3 Business Segmentation
20.4.4 Business Strategy
20.4.5 Key Developments
20.4.6 SWOT Analysis
20.5 Guerbet
20.5.1 Key Facts
20.5.2 Business Overview
20.5.3 Product Segmentation by Revenue 2014
20.5.4 Business Segmentation by Revenue 2013 and 2014
20.5.5 Recent Developments
20.5.6 SWOT Analysis
21. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Contrast MediaContrast Agents Market 2014-2019 ($ billions)
Exhibit 3: Segmentation of Global Contrast MediaContrast Agents Market by Product Type
Exhibit 4: Segmentation of Global Contrast MediaContrast Agents Market by Product Type 2014
Exhibit 5: Commonly Used Iodinated Contrast Agents
Exhibit 6: Commonly Used Gadolinium-based Contrast Agents
Exhibit 7: Global Contrast MediaContrast Agents Market by Medical Procedure 2014
Exhibit 8: Segmentation of Global X-ray Market by Type 2014
Exhibit 9: Comparison of Analog and Digital X-ray Systems
Exhibit 10: Segmentation of Global Digital X-ray Market by Geography 2014
Exhibit 11: Segmentation of Global MRI Scan Market by Geography 2014
Exhibit 12: Segmentation of Global Nuclear Imaging Market by Geography 2014
Exhibit 13: Global Contrast MediaContrast Agents Market by Application 2014
Exhibit 14: Segmentation of Global Contrast MediaContrast Agents Market by Geography 2014 and 2019
Exhibit 15: Contrast MediaContrast Agents Market in North America 2014-2019 ($ billions)
Exhibit 16: Contrast MediaContrast Agents Market in Europe 2014-2019 ($ billions)
Exhibit 17: Contrast MediaContrast Agents Market in APAC 2014-2019 ($ billions)
Exhibit 18: Contrast MediaContrast Agents Market in ROW 2014-2019 ($ billions)
Exhibit 19: New Cancer Cases, Deaths, and 5-Year Relative Survival (number per 1,000,000 persons)
Exhibit 20: Major Countries Per Capita Healthcare Costs ($)
Exhibit 21: GDP Forecast of Major EU Countries 2013-2020 ($ billions)
Exhibit 22: Population Forecast in BRIC Nations 2013-2020 (in millions)
Exhibit 23: Global Contrast MediaContrast Agents Market: Major Vendors in 2014
Exhibit 24: Bayer HealthCare: Business Segmentation by Revenue 2013
Exhibit 25: Bayer HealthCare: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 26: Bayer HealthCare: Geographical Segmentation by Revenue 2013
Exhibit 27: Bracco Diagnostics: Products Categories
Exhibit 28: Covidien: Business Segmentation 2013
Exhibit 29: Covidien: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 30: Covidien: Geographical Segmentation by Revenue 2013
Exhibit 31: GE Healthcare: Business Segmentation 2013
Exhibit 32: Guerbet: Product Segmentation by Revenue 2014
Exhibit 33: Guerbet: Business Segmentation by Revenue 2013 and 2014 ($ million)
